FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Chemcel Biotech IPO.
March 15, 2024 9:37:00 AM
While there may be exceptions and individual stock performances can vary widely, the first-day trading behavior of IPOs often provides insight into the long-term prospects of the biotech sector.
Published by : The UBJ on MSNMarch 14, 2024 2:33:00 PM
with IPO funding of more than $1.2 billion so far this quarter still far below precrash levels, Jefferies data show. That might be a sign that conditions are ideal for investing in new biotech ...
Published by : MSNFebruary 25, 2024 1:24:00 AM
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment.
Published by : India InfolineMarch 6, 2024 7:50:00 PM
Just when it seemed like the biotech IPOs were being lulled back to sleep, Boundless Bio says it plans to hit Wall Street. The Arch-, Bayer- and RA-backed company filed an S-1 Wednesday afternoon ...
Published by : FierceBiotechMarch 5, 2024 2:30:00 AM
Those IPOs, combined with the recovery of biotech�s two flagship stock funds and a dealmaking surge, have given industry watchers reasons to be optimistic. �Some of the trends that are going ...
Published by : Yahoo FinanceMay 5, 2017 3:30:00 AM
The biotech IPO market seems to be heating up after three stock market launches in quick succession, including the largest launch seen in the sector this year. After a boom in 2014 and 2015 ...
Published by : pharmaphorumMay 19, 2020 3:30:00 AM
Legend Biotech is spinning out from parent firm GenScript Biotech to pursue treatments in CAR T cell therapies for multiple myeloma. Legend Biotech is spinning out from parent firm GenScript ...
Published by : TheStreet.comMay 5, 2023 3:30:00 AM
The company raised $540 million from the sale of 30 million shares at $18 apiece, in the largest biotech IPO in the US since Sana Biotech went public in early 2021 with a $588 million raise that ...
Published by : pharmaphorumMarch 14, 2024 3:30:00 PM
The best time to make money in biotech is usually during periods of cautious optimism. There are strong signs that right now might be one of those moments. The always-volatile industry has just ...
Published by : Wall Street JournalMarch 15, 2024 6:19:00 AM
Biotechnology IPOs tend to do well over the long term just as financing markets begin to thaw, an analysis shows. The best time to make money in biotech is usually during periods of cautious optimism.
Published by : MintChemcel Biotech Limited IPO stock listed today at a huge discount of around 68%. An Agro Chemicals manufacturer's fixed price IPO was priced at Rs 16 and closed for subscription on September 12.
Chemcel stock opened at its issue price of Rs 16 and then keeps falling all day. At one point the stock went down to its day low of Rs 4.75. Later the stock recovered a little and finally closed at Rs 5.25, around -68% from its issue price.
Most of the experts told investors not to apply in this IPO. The grey market premiums were running at Rs 2 to Rs 3 just before its listing.
Chemcel Biotech IPO Listing Date & Info:
IPO Listing Date: Monday, October 13, 2008
BSE Script Code: 533026
Listing in: 'B' Group of Securities
ISIN: INE213J01012
Issue Price: Rs 16/- Per Equity Share
Face Value: Rs 10/- Per Equity Share
IPO Allotment Status is now available online for Chemcel Biotech Limited IPO.
Chemcel Biotech IPO was open on September 09, 2008 and closed on September 12, 20.
The Chemcel Biotech IPO is proposed to open on September 9, 2008. The IPO application ends on September 12, 2008.
Retail investors can apply in the retail or non-institutional investor category from September 9, 2008 to September 12, 2008. The Chemcel Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Chemcel Biotech IPO will open for subscription on September 9, 2008. The public issue will close on September 12, 2008.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|